- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms
Total 107167 results
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaRecruiting
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
Stanford UniversityWithdrawnProstate Cancer | Castrate Resistant Prostate Cancer
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Won KimNovartisTerminated
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
Sunnybrook Health Sciences CentreProstate Cancer CanadaUnknownHIGH RISK PROSTATE CANCERCanada
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownCastration-resistant Prostate Cancer
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Sunnybrook Health Sciences CentreSunnybrook Research InstituteUnknownCastrate Resistance Prostate Cancer
-
Hoffmann-La RocheCompleted
-
Spanish Oncology Genito-Urinary GroupAstellas Pharma Inc; Apices Soluciones S.L.CompletedHormone-refractory Prostate CancerSpain
-
NanOlogy, LLCUS Biotest, Inc.CompletedAdenocarcinoma of the ProstateUnited States
-
Peking UniversityWithdrawnHormone Refractory Prostate CancerChina
-
Exact ImagingCompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada, United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage III Prostate Cancer
-
Medical University of South CarolinaNational Cancer Institute (NCI)Completed
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage III Prostate CancerChina
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
AHS Cancer Control AlbertaUnknownHigh-risk Prostate CancerCanada
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...UnknownHormone Refractory Prostate CancerChina
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Virginia Commonwealth UniversityWithdrawnProstate CancerUnited States
-
British Columbia Cancer AgencyCompletedHormone Refractory Prostate CancerCanada
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
Poniard PharmaceuticalsUnknownHormone Refractory Prostate CancerRussian Federation
-
National Cancer Institute (NCI)CompletedProstate Neoplasms | Prostate Specific AntigensUnited States
-
Dana-Farber Cancer InstituteEpizyme, Inc.; PfizerRecruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States